BC
| |
BML Capital Management, LLC13F | |
BML Capital Management, LLC | |
Last update 2025-05-07 | 27 Stocks (6 new) |
Value $124.00 Mil | Turnover 20 % |
BML Capital Management, LLC Top Holdings of 2025-03-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
AVIR | Atea Pharmaceuticals Inc | 7,609,812 | 22,753.3 | +0.02% | 18.410 | 0% | 8.890 | +21.93% | +3.73% | 297.4 | Biotechnology | |
ACRS | Aclaris Therapeutics Inc | 14,250,000 | 21,802.5 | 0% | 17.650 | 0% | 13.160 | +40.06% | -32.79% | 180.5 | Biotechnology | |
THRD | Third Harmonic Bio Inc | 3,824,417 | 13,270.7 | New Holding | 10.740 | +10.74% | 8.470 | +5.53% | -47.18% | 245.3 | Biotechnology | |
ADVM | Adverum Biotechnologies Inc | 2,742,317 | 11,983.9 | +20.91% | 9.700 | +1.68% | 13.130 | -7.02% | -43.25% | 55.4 | Biotechnology | |
ANTX | AN2 Therapeutics Inc | 5,749,432 | 7,819.2 | 0% | 6.330 | 0% | 19.100 | -11.42% | -18.48% | 33.9 | Biotechnology | |
TIL | Instil Bio Inc | 416,720 | 7,234.3 | +4.18% | 5.850 | +0.23% | 6.350 | +43.62% | +54.37% | 193.3 | Biotechnology | |
EPIX | ESSA Pharma Inc | 4,221,546 | 6,670.0 | 0% | 5.400 | 0% | 9.510 | +6.25% | +4.47% | 82.9 | Biotechnology | |
ORMP | Oramed Pharmaceuticals Inc | 3,020,748 | 6,464.4 | +14.25% | 5.230 | +0.65% | 7.390 | -3.03% | -7.44% | 91.5 | Biotechnology | |
IKNA | Ikena Oncology Inc | 3,710,803 | 4,749.8 | +3.48% | 3.840 | +0.13% | 7.690 | +13.22% | -16.46% | 57.4 | Biotechnology | |
PMVP | PMV Pharmaceuticals Inc | 3,747,612 | 4,084.9 | +8.10% | 3.310 | +0.25% | 7.210 | +30.77% | -7.34% | 72.7 | Biotechnology |
BML Capital Management, LLC's Historical Top Holdings Breakdowns
BML Capital Management, LLC's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
SGOV | iShares 0-3 Month Treasury Bond ETF | 2025-03-31 | Sold Out Sold Out | -16.20% | 100.34 ($100.51) 100.68 | $100.62 | 0.11% | Sold Out | 0 | -260,000 | |
THRD | Third Harmonic Bio Inc | 2025-03-31 | New Buy New Buy | +10.74% | 3.25 ($4.85) 11.17 | $5.43 | 12.06% | New holding | 3,824,417 | 3,824,417 | |
LVTX | LAVA Therapeutics NV | 2025-03-31 | New Buy New Buy | +2.02% | 0.91 ($1.11) 1.44 | $1.44 | 29.73% | New holding | 1,960,610 | 1,960,610 | |
ADVM | Adverum Biotechnologies Inc | 2025-03-31 | Add Add | +1.68% | 3.83 ($4.51) 5.6 | $2.70 | -40.13% | Add 20.91% | 2,742,317 | 474,253 | |
KZR | Kezar Life Sciences Inc | 2025-03-31 | Add Add | +1.42% | 4.88 ($6.07) 6.86 | $4.35 | -28.34% | Add 738.62% | 408,138 | 359,470 | |
ELEV | Elevation Oncology Inc | 2025-03-31 | New Buy New Buy | +1.24% | 0.26 ($0.57) 0.84 | $0.36 | -35.96% | New holding | 5,890,934 | 5,890,934 | |
SAGE | Sage Therapeutics Inc | 2025-03-31 | New Buy New Buy | +0.87% | 5.55 ($7.32) 8.66 | $8.74 | 19.47% | New holding | 135,095 | 135,095 | |
ORMP | Oramed Pharmaceuticals Inc | 2025-03-31 | Add Add | +0.65% | 2 ($2.31) 2.62 | $2.24 | -3.03% | Add 14.25% | 3,020,748 | 376,841 | |
WHWK | Whitehawk Therapeutics Inc | 2025-03-31 | Reduce Reduce | -0.41% | 1.78 ($2.61) 3.73 | $1.95 | -25.29% | Reduce -9.99% | 1,890,245 | -209,755 | |
TSBX | Turnstone Biologics Corp | 2025-03-31 | New Buy New Buy | +0.37% | 0.35 ($0.43) 0.58 | $0.36 | -15.86% | New holding | 1,103,386 | 1,103,386 |
BML Capital Management, LLC Total Holding History ($B)
BML Capital Management, LLC's Asset Allocation
BML Capital Management, LLC Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
BML Capital Management, LLC's Hypothetical Growth since 2025-03-31
BML Capital Management, LLC's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
BML Capital Management, LLC's Holdings Heat Map
Size field:
BML Capital Management, LLC's Holdings Bubble Chart
BML Capital Management, LLC News
- 1